Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1769)	4/12/2007 12:41:18 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

GNVC Is trying to go over its Mar-Apr Hs. The stock has been up 11.9% on moderate volume of 530Ks. bigcharts.marketwatch.com On March 29 the Motley Fool had GNVC among its list of"Five Top Microcap Stocks" & stated that it liked the progress GNVC is making with its lead product, TNFerade, which is currently, TF is in a PII-PIII for pancreatic Ca & PII for melanoma & rectal Ca. The UG in Dec was after GNVC said that an independent data safety monitoring board had completed its analysis of safety data from the PII/III of TNFerade in pancreatic Ca. & recommended that the trial continued as planned. Bernard